GL1X · GenesisL1 explorer

Research workbench

X-ray crystallographic structure of ctx-M-9 beta-lactamase covalently linked to cefoxitin

Analyse X-ray crystallographic structure of ctx-M-9 beta-lactamase covalently linked to… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1YMX
Type
protein
Length
523 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase ctx-M-9
EC
3.5.2.6
UniProt
Q9L5C8
Ligands
1QL
Pockets
2 · best druggability 0.32

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase ctx-M-9 (EC 3.5.2.6)protein26243% helix, 19% strandQ9L5C8
BBeta-lactamase ctx-M-9 (EC 3.5.2.6)protein26144% helix, 19% strandQ9L5C8

Ligands and binding sites

  • 1QL · (2R)-5-[(carbamoyloxy)methyl]-2-{(1S)-1-methoxy-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1780.320.75231QL
2800.310.74231QL

Interfaces

1 interface between chains.

  • A–B · 77 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 1YMX · X-ray crystallographic structure of CTX-M-9 beta-lactamase covalently linked to cefoxitin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.